News & Articles

Ready-to-use kit from Gyros Protein Technologies enables the detection of binding antibodies against AAV vectors without the need for serotype-specific assays

Gyros Protein Technologies introduces new automated kit to overcome major bottleneck in peptide production

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in cyno samples

New services to support peptide purification, custom synthesis of PEC-grade peptides, and development and production of peptide drugs and drug candidates

Single analyte biomarker kit reagents introduced for the quantification of five human inflammatory cytokines

Next-generation mid-pilot scale peptide synthesizer provides more reliable, robust, and improved workflows

New kit enables researchers to generate more data in less time to support viral vector bioprocess analytics

Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy

The Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets

Enables researchers to generate more data in less time to support both preclinical and clinical studies

Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors

Flexible, modular system, designed for 21CFR Part 11 compliance

Ready-to-use immunoassay kit designed to increase productivity

Gyrolab Generic TK Kit for early-stage biotherapeutic development

Developed to support assay development and validation for detection of anti-drug antibodies

Kit increases efficiency of residual protein A ligand detection